+1 915 229 3004 (U.S.) | 
+44 7452 242832 (U.K.)
+1 915 229 3004 (U.S.) | +44 7452 242832 (U.K.)
Table of Contents:
1. Executive summary
2. Market Introduction
2.1. Definition
2.2. Scope of the Study
2.2.1. Research Objective
2.2.2. Assumptions
2.2.3. Limitations
3. Research Methodology
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.4.1. Primary Interviews and Information Gathering Process
3.4.2. Breakdown of Primary Respondents
3.5. Forecasting Modality
3.6. Market Size Estimation
3.6.1. Bottom-Up Approach
3.6.2. Top-Down Approach
3.7. Data Triangulation
3.8. Validation
4. Market Dynamics
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities
5. Market Factor Analysis
5.1. Value Chain Analysis
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining Power of Suppliers
5.2.2. Bargaining Power of Buyers
5.2.3. Threat of New Entrants
5.2.4. Threat of Substitutes
5.2.5. Intensity of Rivalry
5.3. COVID-19 Impact Analysis
5.3.1. Market Impact Analysis
5.3.2. Regional Impact
5.3.3. Opportunity and Threat Analysis
6. GLOBAL Antimicrobial Therapeutics MARKET, BY APPLICATION
6.1. Overview
6.2. Antiviral
6.3. Antibacterial
6.4. Antifungal
6.5. Antiparasitic
7. GLOBAL Antimicrobial Therapeutics MARKET, BY End User
7.1. Overview
7.2. Pharmacies
7.3. Hospitals and clinics
7.4. Research and academic institutes
8. GLOBAL Antimicrobial Therapeutics MARKET, by Region
8.1. Overview
8.2. North America
8.2.1. U.S.
8.2.2. Canada
8.3. Europe
8.3.1. Germany
8.3.2. France
8.3.3. U.K
8.3.4. Italy
8.3.5. Spain
8.3.6. Rest of Europe
8.4. Asia-Pacific
8.4.1. China
8.4.2. India
8.4.3. Japan
8.4.4. South Korea
8.4.5. Australia
8.4.6. Rest of Asia-Pacific
8.5. Rest of the World
8.5.1. Middle East
8.5.2. Africa
8.5.3. Latin America
9. Competitive Landscape
9.1. Overview
9.2. Competitive Analysis
9.3. Market Share Analysis
9.4. Major Growth Strategy in the Global Antimicrobial Therapeutics Market,
9.5. Competitive Benchmarking
9.6. Leading Players in Terms of Number of Developments in the Global Antimicrobial Therapeutics Market,
9.7. Key developments and Growth Strategies
9.7.1. New APPLICATION Launch/End User Deployment
9.7.2. Merger & Acquisitions
9.7.3. Joint Ventures
9.8. Major Players Financial Matrix
9.8.1. Sales & Operating Income, 2022
9.8.2. Major Players R&D Expenditure. 2022
10. Company ProfileS
10.1. AbbVie Inc.
10.1.1. Company Overview
10.1.2. Financial Overview
10.1.3. APPLICATIONs Offered
10.1.4. Key Developments
10.1.5. SWOT Analysis
10.1.6. Key Strategies
10.2. Astellas Pharma Inc.
10.2.1. Company Overview
10.2.2. Financial Overview
10.2.3. APPLICATIONs Offered
10.2.4. Key Developments
10.2.5. SWOT Analysis
10.2.6. Key Strategies
10.3. Bavarian Nordic AS
10.3.1. Company Overview
10.3.2. Financial Overview
10.3.3. APPLICATIONs Offered
10.3.4. Key Developments
10.3.5. SWOT Analysis
10.3.6. Key Strategies
10.4. Biocidium Biopharmaceuticals Inc.
10.4.1. Company Overview
10.4.2. Financial Overview
10.4.3. APPLICATIONs Offered
10.4.4. Key Developments
10.4.5. SWOT Analysis
10.4.6. Key Strategies
10.5. Bristol Myers Squibb Co.
10.5.1. Company Overview
10.5.2. Financial Overview
10.5.3. APPLICATIONs Offered
10.5.4. Key Developments
10.5.5. SWOT Analysis
10.5.6. Key Strategies
10.6. CADILA PHARMACEUTICALS LTD.
10.6.1. Company Overview
10.6.2. Financial Overview
10.6.3. APPLICATIONs Offered
10.6.4. Key Developments
10.6.5. SWOT Analysis
10.6.6. Key Strategies
10.7. CSL LTD.
10.7.1. Company Overview
10.7.2. Financial Overview
10.7.3. APPLICATIONs Offered
10.7.4. Key Developments
10.7.5. SWOT Analysis
10.7.6. Key Strategies
10.8. Emergent BioSolutions Inc.
10.8.1. Company Overview
10.8.2. Financial Overview
10.8.3. APPLICATIONs Offered
10.8.4. Key Developments
10.8.5. SWOT Analysis
10.8.6. Key Strategies
10.9. F. HOFFMANN LA ROCHE LTD.
10.9.1. Company Overview
10.9.2. Financial Overview
10.9.3. APPLICATIONs Offered
10.9.4. Key Developments
10.9.5. SWOT Analysis
10.9.6. Key Strategies
10.10. Gilead Sciences Inc.
10.10.1. Company Overview
10.10.2. Financial Overview
10.10.3. APPLICATIONs Offered
10.10.4. Key Developments
10.10.5. SWOT Analysis
10.10.6. Key Strategies
11. Appendix
11.1. References
11.2. Related Reports
LIST OF TABLES
TABLE 1 Global Antimicrobial Therapeutics Market, Synopsis, 2018-2032
TABLE 2 Global Antimicrobial Therapeutics Market, Estimates & Forecast, 2018-2032 (USD BILLION)
TABLE 3 GLOBAL Antimicrobial Therapeutics MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 4 GLOBAL Antimicrobial Therapeutics MARKET, BY END USER, 2018-2032 (USD BILLION)
TABLE 5 North America Antimicrobial Therapeutics MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 6 North America Antimicrobial Therapeutics MARKET, BY END USER, 2018-2032 (USD BILLION)
TABLE 7 North America Antimicrobial Therapeutics MARKET, BY Country, 2018-2032 (USD BILLION)
TABLE 8 U.S. Antimicrobial Therapeutics MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 9 U.S. Antimicrobial Therapeutics MARKET, BY END USER, 2018-2032 (USD BILLION)
TABLE 10 Canada Antimicrobial Therapeutics MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 11 Canada Antimicrobial Therapeutics MARKET, BY END USER, 2018-2032 (USD BILLION)
TABLE 12 Europe Antimicrobial Therapeutics MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 13 Europe Antimicrobial Therapeutics MARKET, BY END USER, 2018-2032 (USD BILLION)
TABLE 14 Europe Antimicrobial Therapeutics MARKET, BY Country, 2018-2032 (USD BILLION)
TABLE 15 Germany Antimicrobial Therapeutics MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 16 Germany Antimicrobial Therapeutics MARKET, BY END USER, 2018-2032 (USD BILLION)
TABLE 17 France Antimicrobial Therapeutics MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 18 France Antimicrobial Therapeutics MARKET, BY END USER, 2018-2032 (USD BILLION)
TABLE 19 Italy Antimicrobial Therapeutics MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 20 Italy Antimicrobial Therapeutics MARKET, BY END USER, 2018-2032 (USD BILLION)
TABLE 21 Spain Antimicrobial Therapeutics MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 22 Spain Antimicrobial Therapeutics MARKET, BY END USER, 2018-2032 (USD BILLION)
TABLE 23 U.K Antimicrobial Therapeutics MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 24 U.K Antimicrobial Therapeutics MARKET, BY END USER, 2018-2032 (USD BILLION)
TABLE 25 Rest of Europe Antimicrobial Therapeutics MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 26 Rest of Europe Antimicrobial Therapeutics MARKET, BY END USER, 2018-2032 (USD BILLION)
TABLE 27 Asia Pacific Antimicrobial Therapeutics MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 28 Asia Pacific Antimicrobial Therapeutics MARKET, BY END USER, 2018-2032 (USD BILLION)
TABLE 29 Asia Pacific Antimicrobial Therapeutics MARKET, BY Country, 2018-2032 (USD BILLION)
TABLE 30 Japan Antimicrobial Therapeutics MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 31 Japan Antimicrobial Therapeutics MARKET, BY END USER, 2018-2032 (USD BILLION)
TABLE 32 China Antimicrobial Therapeutics MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 33 China Antimicrobial Therapeutics MARKET, BY END USER, 2018-2032 (USD BILLION)
TABLE 34 India Antimicrobial Therapeutics MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 35 India Antimicrobial Therapeutics MARKET, BY END USER, 2018-2032 (USD BILLION)
TABLE 36 Australia Antimicrobial Therapeutics MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 37 Australia Antimicrobial Therapeutics MARKET, BY END USER, 2018-2032 (USD BILLION)
TABLE 38 south korea Antimicrobial Therapeutics MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 39 south korea Antimicrobial Therapeutics MARKET, BY END USER, 2018-2032 (USD BILLION)
TABLE 40 Rest of asia-pacific Antimicrobial Therapeutics MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 41 Rest of asia-pacific Antimicrobial Therapeutics MARKET, BY END USER, 2018-2032 (USD BILLION)
TABLE 42 Rest of WOrld Antimicrobial Therapeutics MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 43 Rest of WOrld Antimicrobial Therapeutics MARKET, BY END USER, 2018-2032 (USD BILLION)
TABLE 44 Rest of WOrld Antimicrobial Therapeutics MARKET, BY Country, 2018-2032 (USD BILLION)
TABLE 45 Middle east Antimicrobial Therapeutics MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 46 Middle east Antimicrobial Therapeutics MARKET, BY END USER, 2018-2032 (USD BILLION)
TABLE 47 Africa Antimicrobial Therapeutics MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 48 Africa Antimicrobial Therapeutics MARKET, BY END USER, 2018-2032 (USD BILLION)
TABLE 49 Latin america Antimicrobial Therapeutics MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 50 Latin america Antimicrobial Therapeutics MARKET, BY END USER, 2018-2032 (USD BILLION)
LIST OF FIGURES
FIGURE 1 Research Process
FIGURE 2 Market Structure for the Global Antimicrobial Therapeutics Market
FIGURE 3 Market Dynamics for the Global Antimicrobial Therapeutics Market
FIGURE 4 Global Antimicrobial Therapeutics Market, Share (%), BY APPLICATION, 2022
FIGURE 5 Global Antimicrobial Therapeutics Market, Share (%), BY END USER, 2022
FIGURE 6 Global Antimicrobial Therapeutics Market, Share (%), by Region, 2022
FIGURE 7 north AMERICA: Antimicrobial Therapeutics MARKET, SHARE (%), BY REGION, 2022
FIGURE 8 Europe: Antimicrobial Therapeutics MARKET, SHARE (%), BY REGION, 2022
FIGURE 9 Asia-Pacific: Antimicrobial Therapeutics MARKET, SHARE (%), BY REGION, 2022
FIGURE 10 Rest of the world: Antimicrobial Therapeutics MARKET, SHARE (%), BY REGION, 2022
FIGURE 11 Global Antimicrobial Therapeutics Market: Company Share Analysis, 2022 (%)
FIGURE 12 AbbVie Inc.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 13 AbbVie Inc.: SWOT ANALYSIS
FIGURE 14 Astellas Pharma Inc.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 15 Astellas Pharma Inc.: SWOT ANALYSIS
FIGURE 16 Bavarian Nordic AS: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 17 Bavarian Nordic AS: SWOT ANALYSIS
FIGURE 18 Biocidium Biopharmaceuticals Inc.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 19 Biocidium Biopharmaceuticals Inc.: SWOT ANALYSIS
FIGURE 20 Bristol Myers Squibb Co..: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 21 Bristol Myers Squibb Co..: SWOT ANALYSIS
FIGURE 22 CADILA PHARMACEUTICALS LTD.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 23 CADILA PHARMACEUTICALS LTD.: SWOT ANALYSIS
FIGURE 24 CSL LTD.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 25 CSL LTD.: SWOT ANALYSIS
FIGURE 26 Emergent BioSolutions Inc.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 27 Emergent BioSolutions Inc.: SWOT ANALYSIS
FIGURE 28 F. HOFFMANN LA ROCHE LTD.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 29 F. HOFFMANN LA ROCHE LTD.: SWOT ANALYSIS
FIGURE 30 Gilead Sciences Inc.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 31 Gilead Sciences Inc.: SWOT ANALYSIS
Report Code :
RL6567
Published on :
Aug 2023
Request a Free Sample Report
Speak to Analyst